Robin Mansukhani

Company: Deciduous Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Harnessing the Immune System to Ablate Senescent Cells and Treat Age Related Diseases 12:30 pm

Discovering the underlying immune mechanism responsible for the ablation of senescent cells Using small molecule immune agonists to eliminate senescent cells and resolve multiple classes of diseaseRead more

day: Day One

Harnessing the Immune System to Ablate Senescent Cells and Treat Age Related Diseases 11:30 am

Unlocking the potential benefits of senolytics to promote healthy human aging Tapping into other possible advances including the identification of individuals at a higher risk for age-related diseaseRead more

day: Day One